Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: Results of a double-blind multicenter study

Aging Clinical and Experimental Research

Volumn 5, Issue 1, 1993, Pages 63-71

  Passen, M ^a   Cucinotta, D ^b   Abate, G ^c   Senin, U ^d   Ventura, A ^d   Stramba Badiale, M ^e   Diana, R ^f   La Greca, P ^g   Grazie, Cristina Le ^a,g  

^a UNIVERSITY OF PARMA   (Italy)

^b L Pierantoni Hospital   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e Nursing Home C Golgi ^*  (Italy)

^f Medical Department of S Camillo Hospital ^*  (Italy)

^g Logic Spa   (Italy)

Author keywords

5 Methyltetrahydrofolic acid; Dementia; depression; trazodone

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; PLACEBO; PSYCHOTROPIC AGENT; TRAZODONE;

AGED; ARTICLE; CONTROLLED STUDY; DEMENTIA; DEPRESSION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; ORGANIC BRAIN SYNDROME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; DEMENTIA, MULTI-INFARCT; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; TETRAHYDROFOLATES; TRAZODONE;

EID: 0027502712     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/BF03324128     Document Type: Article

References (47)

1. Observations on the brains of demented old people
2. Depression in Dementia of the Alzheimer type and in Multi-In- farct Dementia
3. Dementia of the Alzheimer’s type and depression
4. Double-blind trial of imipramine in Alzheimer’s disease patients with and without depression
5. Depression and Alzheimer’s disease
6. Dementia with Coexistent Major Depression
7. The pharmacologic treatment of depression
8. Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mionserim
9. Enhancement of recovery from psychiatric illness by methylfolate
10. Open study on 5 methyltetrahydrofolic acid in the treatment of depression in the elderly
11. The Mini Mental State Examination
12. “Mini Mental State”: a practical method for grading the cognitive state of patients for the clinician
13. A rating scale for depression
14. Cerebral blood flow in dementia
15. Methodological problems in studies of depressive disorder: utility of the discontinuation design
16. S- Adenosylmethionine treatment of depression: a controlled clinical trial
17. Memorisation d’une série de 15 mots en 5 repetitions
18. Unilateral and bilateral ECT in elderly patients: a comparative study
19. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly
20. The prognosis of depression in old age
21. Heterogeneity of clinical response during placebo treatment
22. Different types of placebo response in patients receiving antidepressants
23. Short-term forgetting: comparison between patients with dementia of the Alzheimer type, depressed and normal elderly
24. The influence of major depression on clinical and psychometric assessment of senile dementia of the Alzheimer type
25. Depression in patients referred to a dementia clinic: a three year prospective study
26. Psychiatrische komplikationen beim Morbus Parkinson: kranktreitssymptome, Folge der Alterung order der Therapie? Neuropsychiatr
27. Cerebrospinal fluid folate: Clinical studies
28. Regional distribution of 5′-Methyltetrahydrofolic Acid in brain
29. The neuropsychiatry of megaloblastic anaemia
30. Serum folate values in 423 psychiatric patients
31. Serum folic acid and B12 in 272 psychiatric in-patients
32. Red folate concentrations in psychiatric patients
33. Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat
34. Depression and tetrahydrobiopterin: the folate connection
35. CFS tetrahydrobiopterin levels in patients with affective disorders
36. Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer’s presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL)
37. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type
38. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer’s dementia
39. Serotoninergic system in dementia of the Alzheimer type
40. CSF Monoamine metabolites and somatostatin in Alzheimer’s disease and major depression
41. Methylation and mood
42. S-Adenosylmethionine treatment of depression: a controlled clinical trial
43. Oral S-Adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial
44. The antidepressant potential of oral S-adenosyl-L-methionine
45. Cerebrospinal fluid S- adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine
46. Enhancement of recovery from psychiatric illness by methylfolate